top of page
Profile
Join date: Jul 4, 2023
Posts (9)
Nov 13, 2024 ∙ 2 min
Azome Therapeutics Enters into CRADA with National Center for Advancing Translational Sciences to investigate novel inflammasome antagonist to prevent Bronchopulmonary Dysplasia
Collaboration focuses on studies of AZM-152 to enable submission of an Investigational New Drug (IND) application for the prevention of...
94
0
Sep 18, 2024 ∙ 1 min
Azome Therapeutics Presents at 6th Annual Inflammasome Therapeutics Summit
September 18, 2024 Azome Therapeutics, an early-stage drug development company, presented data supporting its Receptor for...
80
0
May 6, 2024 ∙ 1 min
Azome Therapeutics to Present at BioNJ
May 6, 2024 Azome Therapeutics, an early-stage drug development company, announced today that the company will present at the upcoming...
48
0
N-Vision Accounts
Admin
More actions
bottom of page